DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on July 19, 2007; DOI: 10.1124/dmd.107.016261


0090-9556/07/3510-1840-1845$20.00
DMD 35:1840-1845, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.016261v1
35/10/1840    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banks, M. L.
Right arrow Articles by Nader, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banks, M. L.
Right arrow Articles by Nader, M. A.

Ambient Temperature Effects on 3,4-Methylenedioxymethamphetamine-Induced Thermodysregulation and Pharmacokinetics in Male Monkeys

Matthew L. Banks, Jon E. Sprague, David F. Kisor, Paul W. Czoty, David E. Nichols, and Michael A. Nader

Departments of Physiology and Pharmacology (M.L.B., P.W.C., M.A.N.) and Radiology (M.A.N.), Wake Forest University School of Medicine, Winston-Salem, North Carolina; Department of Pharmaceutical and Biomedical Sciences, Raabe College of Pharmacy, Ohio Northern University, Ada, Ohio (J.E.S., D.F.K.); and Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Purdue University, West Lafayette, Indiana (D.E.N.)

Changes in ambient temperature are known to alter both the hyperthermic and the serotonergic consequences of 3,4-methylenedioxymethamphetamine (MDMA). Metabolism of MDMA has been suggested to be a requisite for these neurotoxic effects, whereas the hyperthermic response is an important contributing variable. The aim of the present study was to investigate the interaction between ambient temperature, MDMA-induced thermodysregulation, and its metabolic disposition in monkeys. MDMA (1.5 mg/kg i.v.) was administered noncontingently at cool (18°C; n = 5), room (24°C; n = 7), and warm (31°C; n = 7) ambient temperatures. For 240 min following MDMA administration, core temperature was recorded and blood samples were collected for analysis of MDMA and its metabolites 3,4-dihydroxymethamphetamine (HHMA), 3,4-dihydroxyamphetamine, and 3,4-methylenedioxyamphetamine (MDA). A dose of 1.5 mg/kg MDMA induced a hypothermic response at 18°C, a hyperthermic response at 31°C, and did not significantly change core temperature at 24°C. Regardless of ambient temperature, plasma MDMA concentrations reached maximum within 5 min, and HHMA was a major metabolite. Curiously, the approximate elimination half-life (t1/2) of MDMA at 18°C (136 min) and 31°C (144 min) was increased compared with 24°C (90 min) and is most likely because of volume of distribution changes induced by core temperature alterations. At 18°C, there was a significantly higher MDA area under the concentration-time curve (AUC) and a trend for a lower HHMA AUC compared with 24°C and 31°C, suggesting that MDMA disposition was altered. Overall, induction of hypothermia in a cool environment by MDMA may alter its disposition. These results could have implications for MDMA-induced serotonergic consequences.


Address correspondence to: Michael A. Nader, Ph.D., Department of Physiology and Pharmacology, Wake Forest University Health Sciences, Medical Center Blvd., NRC Room 546, Winston-Salem, NC 27157-1083. E-mail: mnader{at}wfubmc.edu




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
M. H. Baumann, D. Zolkowska, I. Kim, K. B. Scheidweiler, R. B. Rothman, and M. A. Huestis
Effects of Dose and Route of Administration on Pharmacokinetics of ({+/-})-3,4-Methylenedioxymethamphetamine in the Rat
Drug Metab. Dispos., November 1, 2009; 37(11): 2163 - 2170.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Mueller, J. Yuan, A. Felim, A. Neudorffer, F. T. Peters, H. H. Maurer, U. D. McCann, M. Largeron, and G. A. Ricaurte
Further Studies on the Role of Metabolites in ({+/-})-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity
Drug Metab. Dispos., October 1, 2009; 37(10): 2079 - 2086.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
M. A Nader, P. W Czoty, R. W Gould, and N. V Riddick
Positron emission tomography imaging studies of dopamine receptors in primate models of addiction
Phil Trans R Soc B, October 12, 2008; 363(1507): 3223 - 3232.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.